UNCY News

Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit

What's Next for Unicycive Therapeutics, Inc. Shareholders After 39.1% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline

Contact Levi & Korsinsky by November 2, 2026 to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)

UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before November 2, 2026 - Contact Levi & Korsinsky

Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to a Securities Class Action Deadline - Contact the Firm Before November 2, 2026

Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY) - Recover Losses - Contact Levi & Korsinsky Before November 2, 2026

What Does Unicycive Therapeutics, Inc.'s 39.1% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Contact Levi & Korsinsky by November 2, 2026 to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)

Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY) - Recover Losses - Contact Levi & Korsinsky Before November 2, 2026